Fistula
·MeSH: Rectovaginal Fistula
Prevalence
30.0 / 100K
2 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| avsola | AMGEN INC (AMGN) |
Phase 2(1)
| Drug | Company |
|---|---|
| db-3q | HCW Biologics Inc. (HCWB) |
Compare drugs
Frequently asked questions
How many drugs are in development for Fistula?
BioSniper tracks 2 drugs in development for Fistula across 2 companies.
How many clinical trials target Fistula?
There are 1 clinical trial targeting Fistula tracked by BioSniper.
What is the prevalence of Fistula?
The estimated prevalence of Fistula is approximately 30.0 per 100,000 population.
Deep-dive into Fistula
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis